The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal ...

The CDMO market is poised for growth due to rising R&D spending, increased demand for generics and biologics, patent ...

The award, for uncovering predatory state towing practices, marks ProPublica’s 9th Pulitzer; two additional investigations ...

DRL is the first company to receive market authorisation for a generic semaglutide injection in Canada. It is the first ...

Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, ...

New legislation would authorize pharmacists to substitute a biosimilar when filling a prescription, just like a generic, provided your doctor agrees.

According to the latest market analysis by Future Market Insights, the global small molecule API market is entering a phase of stable and sustained ...

This article provides an overview of the regulatory regime and associated intellectual property rights for veterinary drug ...

Why do Americans pay so much more for prescription drugs than patients in other developed countries? A HelloNation article breaks down the layered factors behind the drug pricing system in the United ...

Major domestic pharmaceutical companies are accelerating organizational restructuring by successively replacing their heads of research and ...

Health Canada has approved a second generic version of semaglutide, the active ingredient in Ozempic, Wegovy and Mounjaro, from Canadian firm Apotex. This follows the country’s first generic approval ...

Health Canada has approved a second generic version of semaglutide, the active ingredient in Ozempic, shortly after authorizing the first. The latest approval, for Toronto-based Apotex, makes Canada ...